Moringa
HerbalAlso called · 5 names▾▴
Moringa oleifera, Moringa pterygosperma, Malunggay, Moringa leaves, Moringa leaf powder
Herbal supplement (milk supply)
Herbs and supplements are not FDA-approved before sale. About these sources
- Powder
- Capsule/tablet
- Food / spice
- Other
Research strength: 2 / 5
MotherToBaby’s general herbal-products sheet says many herbal supplements have not been evaluated during pregnancy, but it does not discuss Moringa specifically. One small trial described its participants as first-trimester pregnancies, while also saying treatment ran from 12 to 20 weeks; it did not report results by trimester. The 2024 review found small pregnancy studies with incomplete dose and preparation details, and the sources reviewed provide no Moringa-specific birth-defect or miscarriage estimates. These findings do not characterize Moringa exposure during the first trimester. Ask your provider about your situation.
Last reviewed: 2026-10-14
Sources
- MotherToBaby: Herbal ProductsTeratology service
- Iskandar et al., 2015 pregnancy trial
- Kalam et al., 2024 systematic review and meta-analysis
Research strength: 3 / 5
MotherToBaby’s general herbal-products sheet notes that many herbal supplements have not been evaluated during pregnancy and does not discuss Moringa specifically. The 2024 review included studies across pregnancy, mostly among people with anemia, but did not report results by trimester or a clear dose and preparation for many trials. The sources reviewed do not establish Moringa-specific second-trimester effects on miscarriage, birth defects, or other pregnancy outcomes. This leaves second-trimester evidence too limited to characterize use. Ask your provider about your situation.
Last reviewed: 2026-10-14
Sources
- MotherToBaby: Herbal ProductsTeratology service
- Iskandar et al., 2015 pregnancy trial
- Kalam et al., 2024 systematic review and meta-analysis
Research strength: 3 / 5
Hadju et al. studied 38 people with anemia in the third trimester using Moringa leaf powder for two months, but the trial focused on anemia and had baseline differences in stress and cortisol between groups. The 2024 review found small trials, incomplete dose and preparation details, and low or very low certainty for the pregnancy outcomes it assessed. The sources do not provide trimester-specific evidence on birth defects or miscarriage. These sources do not characterize broader third-trimester effects. Ask your provider about your situation.
Last reviewed: 2026-10-14
Sources
- MotherToBaby: Herbal ProductsTeratology service
- Hadju et al., 2020 third-trimester randomized trial
- Kalam et al., 2024 systematic review and meta-analysis
Moringa — Breastfeeding
Research strength: 3 / 5
LactMed says Moringa leaves are traditionally used to promote milk production and summarizes a 14-study review that reported increased milk volume. Cochrane’s broader review found natural galactagogue evidence very uncertain, while ABM’s 2018 protocol described the research as inconclusive. In a 2022 randomized trial, the milk-volume increase on postpartum day 3 was not statistically clear; the 2025 Kenya pilot reported more expressed milk, but one hospital was assigned to each group, so treatment and site effects could not be separated. LactMed says long-term infant outcomes have not been well studied and notes a possible clotting effect based on limited evidence. Ask your provider about your situation.
Last reviewed: 2026-10-14
Sources
- LactMed (NIH): MoringaUS government
- Cochrane: Milk boosters (galactagogues) for mothers breastfeeding healthy term infantsResearch review
- Academy of Breastfeeding Medicine Clinical Protocol #9Professional society
- Fungtammasan and Phupong, 2022 randomized trialUS government
- Attia et al., 2025 Kenya pilot trialUS government
- Golshan-Tafti et al., 2026 systematic review and meta-analysis
- Ebhohon and Miller, 2022 pulmonary embolism case reportUS government
Pregnancy
Most human pregnancy evidence comes from small trials in people with anemia that test hemoglobin or iron measures, not Moringa-only effects on a broad range of pregnancy outcomes. Iskandar et al. described participants as first-trimester pregnancies, but the paper says the 90-day intervention ran from 12 to 20 weeks and gives no trimester-specific analysis; the Moringa dose is unclear. Hadju et al. tested 2 g/day of leaf powder for two months in 38 people during the third trimester. The abstract reports a higher average birth weight in the Moringa group, but baseline stress and cortisol differed between groups, and the paper gives different figures in the abstract, adjusted analysis, and discussion. Kalam et al.’s 2024 review included 15 trials with 808 anemic pregnant participants, noted small samples and incomplete dose information, and rated some outcomes very low certainty. Its add-on comparison found no significant difference in baby weight, while a separate one-trial comparison with iron reported a low-certainty positive estimate. MotherToBaby’s herbal-products page is general and does not provide Moringa-specific miscarriage or birth-defect estimates. A 2024 study of Moringa plus royal jelly and a 2025 follow-up using the same combined product cannot isolate Moringa’s effects.
Breastfeeding
Traditional use, food use, and trial evidence are different: LactMed says Moringa leaves have been used as a galactagogue in parts of Asia, but that history alone does not establish an effect. LactMed summarizes a 2026 Moringa-specific review of 14 studies and 865 participants that reports increased milk volume and prolactin; the review includes varied outcomes, quasi-experimental designs, and limited long-term follow-up. The 2022 Thai randomized trial assigned 88 mothers to 900 mg/day of leaf powder or placebo for three days; the 47% greater milk volume on day 3 was not statistically significant, and six-month exclusive breastfeeding rates did not differ. Attia et al.’s 2025 Kenya pilot gave 20 g/day of leaf powder in porridge for three months to 50 mother-infant pairs and reported higher expressed milk volume, but it had only two hospital clusters, one per group. The authors say treatment and location effects cannot be separated and the P values are exploratory rather than confirmatory; infant growth did not differ, and the study was underpowered to detect a change in infant growth. A 2026 dose study was a 14-day quasi-experiment among 89 postpartum participants, not a placebo-controlled trial, and it found no significant differences among the three dose groups. A 2025-2026 systematic review of galactagogues for mothers of preterm infants found low-certainty evidence across herbal products and called for better trials; it does not establish a Moringa-specific dose or result for term infants. A 2022 case report described pulmonary embolism in a 63-year-old after five months of leaf-extract use; a single case cannot establish cause. LactMed notes a possible clotting effect and advises caution for people at high risk of blood clots. Long-term effects on breastfed infants have not been well studied.
Moringa products are made from different plant parts and preparations, including leaf powder, extracts, and foods containing leaves. LactMed notes that leaves contain vitamins, minerals, amino acids, and glycosides. Trial preparations range from leaf powder and extracts to porridge, soup, and cookies, so results from one form or dose may not apply to another. Some studies combine Moringa with iron, folic acid, royal jelly, or other ingredients; those studies cannot identify a Moringa-only effect. MotherToBaby says herbal supplements can vary in ingredients and strength and that some products may contain unlisted ingredients or contaminants. This general supplement information does not show that all Moringa products are contaminated.
What was tested
Pregnancy trials mainly studied people with anemia and measured maternal blood outcomes; several used leaf powder, extract, food, or mixed preparations, and doses were often missing. Iskandar et al. reported a 90-day extract intervention from 12 to 20 weeks but did not state a clear amount or analyze results by trimester. Hadju et al. studied 2 g/day of leaf powder for two months in the third trimester. The 2024 systematic review included 15 trials and 808 participants, all from Indonesia, and noted small samples, risk-of-bias concerns, varied preparations, and incomplete dose reporting. A 2024 quasi-experimental study used Moringa plus royal jelly, and a 2025 follow-up compared the combined product with a multi-micronutrient supplement; neither isolates Moringa. Breastfeeding studies include a 2022 placebo-controlled trial of 900 mg/day of leaf powder for three days, a 2025 two-hospital cluster pilot using 20 g/day of powder in porridge, and a 2026 quasi-experiment comparing 250, 650, and 800 mg/day of extract for 14 days. The 2026 Moringa-specific review pooled randomized and quasi-experimental studies. These preparations and study designs are not interchangeable.
How strong is the evidence that Moringa increases milk production?
- Source A says
- LactMed’s July 2026 revision and a 2026 Moringa-specific review report increased milk volume or prolactin across 14 studies. The review authors describe the pooled result as evidence of a possible benefit. (LactMed (NIH): Moringa, Golshan-Tafti et al., 2026 systematic review and meta-analysis)
- Source B says
- Cochrane’s 2020 review said the natural galactagogue milk-volume results were very uncertain. ABM’s 2018 protocol said the broader research on herbal and drug galactagogues remained inconclusive and did not recommend a specific galactagogue. (Cochrane: Milk boosters (galactagogues) for mothers breastfeeding healthy term infants, Academy of Breastfeeding Medicine Clinical Protocol #9, second revision)
- Why they differ
- The Moringa-specific review was published later and included studies with different measures and designs, including quasi-experimental studies. Cochrane searched through November 2019 and considered many different natural products, while the ABM protocol predates newer Moringa studies. The reviews also use different standards and populations.
- Other sources
- A 2026 review of herbal galactagogues in mothers of preterm infants found low-certainty evidence across products and called for higher-quality trials; it does not establish a Moringa-specific result for term infants. (Cragg et al., 2026 systematic review of galactagogues in preterm populations)
- What the evidence shows overall
- The newer Moringa-specific review adds evidence, but it does not remove the limits of small trials, varied preparations, short follow-up, and the two-cluster design of the 2025 Kenya pilot. The 2022 placebo-controlled trial did not find a statistically clear increase on its measured day. A possible milk-supply benefit can be described, but not as an established result for every product or population. Keep breastfeeding at guidance and 3 stars.
Do the pregnancy studies establish a Moringa effect on newborn birth weight?
- Source A says
- Hadju et al.’s small third-trimester trial reported a higher average birth weight in its Moringa group, but the paper gives inconsistent figures across its abstract, adjusted analysis, and discussion. (Hadju et al., 2020 third-trimester randomized trial)
- Source B says
- Kalam et al.’s 2024 review found no significant baby-weight difference in the Moringa add-on comparison; its separate Moringa-versus-iron comparison contained one small trial and was rated low certainty. (Kalam et al., 2024 systematic review and meta-analysis)
- Why they differ
- The comparison groups differ, and the review judged the available outcome evidence low or very low certainty. The Hadju trial had 38 analyzed participants and baseline differences in stress and cortisol. MotherToBaby’s general herbal-products page does not provide a Moringa-specific birth-weight estimate.
- Other sources
- MotherToBaby says pregnancy research is limited for most herbal products; its page does not assess Moringa or independently confirm a birth-weight effect. (MotherToBaby: Herbal Products)
- What the evidence shows overall
- The single-trial result is not enough to describe a Moringa birth-weight benefit as established or to generalize it to other trimesters, products, or populations. The conflicting figures in the primary paper remain unresolved. Keep all pregnancy ratings at insufficient.
How should the different MOGO product test results be described?
- Source A says
- FDA reported that state partners found Salmonella in opened consumer containers of MOGO capsules, including a container positive for the outbreak strain. (FDA: Outbreak investigation of Salmonella linked to MOGO Moringa capsules)
- Source B says
- MOGO’s recall announcement said third-party testing of retained samples from the affected lots did not detect Salmonella and identified only two recalled lots. (MOGO Moringa LLC recall announcement hosted by FDA)
- Why they differ
- The notices describe different samples: opened consumer containers tested by state partners versus retained company samples. They do not say the same samples were tested.
- What the evidence shows overall
- FDA’s outbreak findings and the company’s retained-sample result should both be attributed. The recall remains limited to the named MOGO lots; these findings do not show that every Moringa product is affected.
- Cochrane says that factors such as maternal and infant health, sucking skills, latch, and feeding frequency can affect milk production and should be addressed before trying a milk booster. (Cochrane)
- ABM says to evaluate medical causes of low milk supply and assess the frequency and effectiveness of milk removal. (Academy of Breastfeeding Medicine)
- LactMed says results from clinical testing of one supplement product may not apply to other products because ingredients and amounts can vary. (LactMed)
General research, not specific to pregnancy.
FDA notices describe recalls for named Moringa products and lots, not all Moringa products. FDA and MOGO reported different test results from different samples for two recalled capsule lots. FDA and Hong Kong’s Centre for Food Safety also described a separate Foods Alive powder recall with specific package identifiers. The product notices do not establish contamination across the broader Moringa category.
- FDA’s investigation concerned MOGO-brand capsules from lot 15525AA, expiring 06/2027, and lot 00926AA, expiring 01/2028. FDA reported positive Salmonella results from opened consumer containers, while MOGO’s notice said its retained samples tested negative. The company stated that no other lots or its other products were included in that recall. (FDA: Outbreak investigation of Salmonella linked to MOGO Moringa capsules, MOGO Moringa LLC recall announcement hosted by FDA)
- A separate FDA notice named Foods Alive Organic Moringa Leaf Powder in an 8-ounce pouch with freshest-by date 110127 and code 02726, shipped from January 27 through August 7, 2026. FDA’s company notice said no illnesses had been reported as of September 4, 2026. Hong Kong’s Centre for Food Safety posted the notice on September 7 and said its preliminary check found no local sale or import, while online purchase or international travel could not be excluded. (Foods Alive recall announcement hosted by FDA, Hong Kong Centre for Food Safety recall notice)
- MotherToBaby: Herbal ProductsTeratology serviceSecondaryIndependent check
- LactMed (NIH): MoringaUS governmentSecondaryPage dated 2026-07-15Independent check
- Academy of Breastfeeding Medicine Clinical Protocol #9, second revisionProfessional societySecondaryIndependent check
- Cochrane: Milk boosters (galactagogues) for mothers breastfeeding healthy term infantsResearch reviewPrimaryIndependent check
- Iskandar et al., 2015 pregnancy trialPrimaryIndependent check
- Hadju et al., 2020 third-trimester randomized trialPrimary
- Kalam et al., 2024 systematic review and meta-analysisPrimaryIndependent check
- Fitriani et al., 2024 Moringa-plus-royal-jelly pregnancy studyPrimary
- Alam et al., 2025 Moringa-plus-royal-jelly breastfeeding follow-upPrimary
- Fungtammasan and Phupong, 2022 randomized trialUS governmentPrimaryIndependent check
- Attia et al., 2025 Kenya pilot trialUS governmentPrimaryIndependent check
- Golshan-Tafti et al., 2026 systematic review and meta-analysisPrimaryPage dated 2026-04-28
- Cragg et al., 2026 systematic review of galactagogues in preterm populationsUS governmentPrimaryPage dated 2025-12-05Independent check
- Irmawati and Rahfiludin, 2026 Moringa dose-response lactation studyPrimary
- Ebhohon and Miller, 2022 pulmonary embolism case reportUS governmentAnecdotalPage dated 2022-04-12
- FDA: Outbreak investigation of Salmonella linked to MOGO Moringa capsulesUS governmentSecondaryPage dated 2026-07-17Independent check
- MOGO Moringa LLC recall announcement hosted by FDAUS governmentTertiaryPage dated 2026-05-25
- Foods Alive recall announcement hosted by FDAUS governmentTertiaryPage dated 2026-09-04
- Hong Kong Centre for Food Safety recall noticeSecondaryPage dated 2026-09-07Independent check
Last reviewed 2026-10-14
Independent check 2026-10-14
Not yet clinician-reviewed
Ask your provider about your situation.
Related
- Blessed Thistle
- Fenugreek
- Goat’s Rue